| Literature DB >> 34526861 |
Natasha Barone1, Tyler Safran2, Joshua Vorstenbosch2, Peter G Davison2, Sabrina Cugno2, Amanda M Murphy2,3.
Abstract
Hypertrophic scars and keloids are caused by excessive tissue response to dermal injury due to local fibroblast proliferation and collagen overproduction. This response occurs because of pathologic wound healing due to dysregulation in the inflammatory, proliferative, and/or remodeling phase. Patients with hypertrophic scars or keloids report reduced quality of life, physical status, and psychological health. Hypertrophic scars or keloids will develop in 30 to 90% of individuals, and despite their prevalence, treatment remains a challenge. Of the treatments currently available for hypertrophic scars and keloids few have been adequately supported by studies with appropriate experimental design. Here, we aim to review the available literature to provide up-to-date information on the etiology, epidemiology, histology, pathophysiology, prevention, and management options available for the treatment of hypertrophic scars and keloids and highlight areas where further research is required. Thieme. All rights reserved.Entities:
Keywords: fibrosis; hypertrophic scar; keloid; scarring
Year: 2021 PMID: 34526861 PMCID: PMC8432993 DOI: 10.1055/s-0041-1731461
Source DB: PubMed Journal: Semin Plast Surg ISSN: 1535-2188 Impact factor: 2.195